253 related articles for article (PubMed ID: 20121258)
1. Signal transducer and activator of transcription 6 (STAT6) is a novel interactor of annexin A2 in prostate cancer cells.
Das S; Shetty P; Valapala M; Dasgupta S; Gryczynski Z; Vishwanatha JK
Biochemistry; 2010 Mar; 49(10):2216-26. PubMed ID: 20121258
[TBL] [Abstract][Full Text] [Related]
2. Signal transducer and activator of transcription-6 (STAT6) is a constitutively expressed survival factor in human prostate cancer.
Das S; Roth CP; Wasson LM; Vishwanatha JK
Prostate; 2007 Oct; 67(14):1550-64. PubMed ID: 17705178
[TBL] [Abstract][Full Text] [Related]
3. Unphosphorylated STAT6 contributes to constitutive cyclooxygenase-2 expression in human non-small cell lung cancer.
Cui X; Zhang L; Luo J; Rajasekaran A; Hazra S; Cacalano N; Dubinett SM
Oncogene; 2007 Jun; 26(29):4253-60. PubMed ID: 17237818
[TBL] [Abstract][Full Text] [Related]
4. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
Zerbini LF; Wang Y; Cho JY; Libermann TA
Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
[TBL] [Abstract][Full Text] [Related]
5. SPI-C and STAT6 can cooperate to stimulate IgE germline transcription.
Carlsson R; Thorell K; Liberg D; Leanderson T
Biochem Biophys Res Commun; 2006 Jun; 344(4):1155-60. PubMed ID: 16647686
[TBL] [Abstract][Full Text] [Related]
6. Signaling mechanisms, interaction partners, and target genes of STAT6.
Hebenstreit D; Wirnsberger G; Horejs-Hoeck J; Duschl A
Cytokine Growth Factor Rev; 2006 Jun; 17(3):173-88. PubMed ID: 16540365
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel Stat6 regulated proteins in IL-4-treated mouse lymphocytes.
Tuomela S; Rautajoki KJ; Moulder R; Nyman TA; Lahesmaa R
Proteomics; 2009 Feb; 9(4):1087-98. PubMed ID: 19180534
[TBL] [Abstract][Full Text] [Related]
8. Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma.
Mohammad HS; Kurokohchi K; Yoneyama H; Tokuda M; Morishita A; Jian G; Shi L; Murota M; Tani J; Kato K; Miyoshi H; Deguchi A; Himoto T; Usuki H; Wakabayashi H; Izuishi K; Suzuki Y; Iwama H; Deguchi K; Uchida N; Sabet EA; Arafa UA; Hassan AT; El-Sayed AA; Masaki T
Int J Oncol; 2008 Dec; 33(6):1157-63. PubMed ID: 19020748
[TBL] [Abstract][Full Text] [Related]
9. SOX9 is expressed in normal prostate basal cells and regulates androgen receptor expression in prostate cancer cells.
Wang H; McKnight NC; Zhang T; Lu ML; Balk SP; Yuan X
Cancer Res; 2007 Jan; 67(2):528-36. PubMed ID: 17234760
[TBL] [Abstract][Full Text] [Related]
10. The Fer tyrosine kinase cooperates with interleukin-6 to activate signal transducer and activator of transcription 3 and promote human prostate cancer cell growth.
Zoubeidi A; Rocha J; Zouanat FZ; Hamel L; Scarlata E; Aprikian AG; Chevalier S
Mol Cancer Res; 2009 Jan; 7(1):142-55. PubMed ID: 19147545
[TBL] [Abstract][Full Text] [Related]
11. Regulation of human prostate-specific G-protein coupled receptor, PSGR, by two distinct promoters and growth factors.
Weng J; Ma W; Mitchell D; Zhang J; Liu M
J Cell Biochem; 2005 Dec; 96(5):1034-48. PubMed ID: 16149059
[TBL] [Abstract][Full Text] [Related]
12. PCOTH, a novel gene overexpressed in prostate cancers, promotes prostate cancer cell growth through phosphorylation of oncoprotein TAF-Ibeta/SET.
Anazawa Y; Nakagawa H; Furihara M; Ashida S; Tamura K; Yoshioka H; Shuin T; Fujioka T; Katagiri T; Nakamura Y
Cancer Res; 2005 Jun; 65(11):4578-86. PubMed ID: 15930275
[TBL] [Abstract][Full Text] [Related]
13. MIEN1, a novel interactor of Annexin A2, promotes tumor cell migration by enhancing AnxA2 cell surface expression.
Kpetemey M; Dasgupta S; Rajendiran S; Das S; Gibbs LD; Shetty P; Gryczynski Z; Vishwanatha JK
Mol Cancer; 2015 Aug; 14():156. PubMed ID: 26272794
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase Cepsilon interacts with signal transducers and activators of transcription 3 (Stat3), phosphorylates Stat3Ser727, and regulates its constitutive activation in prostate cancer.
Aziz MH; Manoharan HT; Church DR; Dreckschmidt NE; Zhong W; Oberley TD; Wilding G; Verma AK
Cancer Res; 2007 Sep; 67(18):8828-38. PubMed ID: 17875724
[TBL] [Abstract][Full Text] [Related]
15. ERG oncoprotein inhibits ANXA2 expression and function in prostate cancer.
Griner NB; Young D; Chaudhary P; Mohamed AA; Huang W; Chen Y; Sreenath T; Dobi A; Petrovics G; Vishwanatha JK; Sesterhenn IA; Srivastava S; Tan SH
Mol Cancer Res; 2015 Feb; 13(2):368-79. PubMed ID: 25344575
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering RNAs suppresses growth of human prostate tumor in vivo.
Gao L; Zhang L; Hu J; Li F; Shao Y; Zhao D; Kalvakolanu DV; Kopecko DJ; Zhao X; Xu DQ
Clin Cancer Res; 2005 Sep; 11(17):6333-41. PubMed ID: 16144938
[TBL] [Abstract][Full Text] [Related]
17. The mRNA-binding site of annexin A2 resides in helices C-D of its domain IV.
Aukrust I; Hollås H; Strand E; Evensen L; Travé G; Flatmark T; Vedeler A
J Mol Biol; 2007 May; 368(5):1367-78. PubMed ID: 17395201
[TBL] [Abstract][Full Text] [Related]
18. Anxa2 plays a critical role in enhanced invasiveness of the multidrug resistant human breast cancer cells.
Zhang F; Zhang L; Zhang B; Wei X; Yang Y; Qi RZ; Ying G; Zhang N; Niu R
J Proteome Res; 2009 Nov; 8(11):5041-7. PubMed ID: 19764771
[TBL] [Abstract][Full Text] [Related]
19. Annexin II expression is reduced or lost in prostate cancer cells and its re-expression inhibits prostate cancer cell migration.
Liu JW; Shen JJ; Tanzillo-Swarts A; Bhatia B; Maldonado CM; Person MD; Lau SS; Tang DG
Oncogene; 2003 Mar; 22(10):1475-85. PubMed ID: 12629510
[TBL] [Abstract][Full Text] [Related]
20. An IgE-associated polymorphism in STAT6 alters NF-kappaB binding, STAT6 promoter activity, and mRNA expression.
Schedel M; Frei R; Bieli C; Cameron L; Adamski J; Lauener R; Kabesch M
J Allergy Clin Immunol; 2009 Sep; 124(3):583-9, 589.e1-6. PubMed ID: 19665768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
